Trinucleotide repeats: A structural perspective

Frontiers in Neurology

Volumn 4 JUN, Issue , 2013, Pages

  Almeida, Bruno ^a   Fernandes, Sara ^a,b   Abreu, Isabel A ^a,c   Macedo Ribeiro, Sandra ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b Athletic Rehabilitation Therapy Ireland   (Ireland)

^c Inst de Tecn   (Portugal)

Author keywords

Amino acid repeats; Amyloid; Microsatellites; Protein aggregation; Protein complexes; Protein structure

Indexed keywords

ATAXIN 3; CARRIER PROTEIN; POLYGLUTAMINE;

ALTERNATIVE RNA SPLICING; CAG REPEAT; FRAGILE X ASSOCIATED TREMOR ATAXIA SYNDROME; FRIEDREICH ATAXIA; GENETIC VARIABILITY; HUMAN; MACHADO JOSEPH DISEASE; MONOGENIC DISORDER; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN HOMEOSTASIS; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RNA STRUCTURE; SIGNAL TRANSDUCTION; SIMPLE SEQUENCE REPEAT; SPINOCEREBELLAR DEGENERATION; TRANSCRIPTION REGULATION; TRINUCLEOTIDE REPEAT;

EID: 84883533687     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00076     Document Type: Review

References (208)

1. Alba, M. M., and Guigo, R. (2004). Comparative analysis of amino acid repeats in rodents and humans. Genome Res. 14, 549-554. doi:10.1101/gr.1925704
2. Albrecht, M., Golatta, M., Wullner, U., and Lengauer, T. (2004). Structural and functional analysis of ataxin-2 and ataxin-3. Eur. J. Biochem. 271, 3155-3170. doi:10.1111/j.1432-1033.2004.04245.x
3. Altschuler, E. L., Hud, N. V., Mazrimas, J. A., and Rupp, B. (1997). Random coil conformation for extended polyglutamine stretches in aqueous soluble monomeric peptides. J. Pept. Res. 50, 73-75. doi:10.1111/j.1399-3011.1997.tb00622.x
4. Amiel, J., Trochet, D., Clement-Ziza, M., Munnich, A., and Lyonnet, S. (2004). Polyalanine expansions in human. Hum. Mol. Genet. 2, R235-243. doi:10.1093/hmg/ddh251
5. Antony, P. M., Mantele, S., Mollenkopf, P., Boy, J., Kehlenbach, R. H., Riess, O., et al. (2009). Identification and functional dissection of localization signals within ataxin-3. Neurobiol. Dis. 36, 280-292. doi:10.1016/j.nbd.2009.07.020
6. Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., and Finkbeiner, S. (2004). Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810. doi:10.1038/nature02998
7. Banerjee, A., Apponi, L. H., Pavlath, G. K., and Corbett, A. H. (2013). PABPN1: molecular function and muscle disease. FEBS J. doi:10.1111/febs.12294
8. Beckwith, A. C., Wall, J. S., and Jordan, R. W. (1965). Reversible reduction and reoxidation of the disulfide bonds in wheat gliadin. Arch. Biochem. Biophys. 112, 16-24. doi:10.1016/0003-9861(65)90004-4
9. Berke, S. J., Chai, Y., Marrs, G. L., Wen, H., and Paulson, H. L. (2005). Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3. J. Biol. Chem. 280, 32026-32034. doi:10.1074/jbc.M506084200
10. Bevivino, A. E., and Loll, P. J. (2001). An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel beta-fibrils. Proc. Natl. Acad. Sci. U.S.A. 98, 11955-11960. doi:10.1073/pnas.211305198
11. Bhattacharyya, A., Thakur, A. K., Chellgren, V. M., Thiagarajan, G., Williams, A. D., Chellgren, B. W., et al. (2006). Oligoproline effects on polyglutamine conformation and aggregation. J. Mol. Biol. 355, 524-535. doi:10.1016/j.jmb.2005.10.053
12. Bichelmeier, U., Schmidt, T., Hubener, J., Boy, J., Ruttiger, L., Habig, K., et al. (2007). Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J. Neurosci. 27, 7418-7428. doi:10.1523/JNEUROSCI.4540-06.2007
13. Blum, E. S., Abraham, M. C., Yoshimura, S., Lu, Y., and Shaham, S. (2012). Control of nonapoptotic developmental cell death in Caenorhabditis elegans by a polyglutamine-repeat protein. Science 335, 970-973. doi:10.1126/science.1215156
14. Blum, E. S., Schwendeman, A. R., and Shaham, S. (2013). PolyQ disease: misfiring of a developmental cell death program? Trends Cell Biol. 23, 168-174. doi:10.1016/j.tcb.2012.11.003
15. Boeddrich, A., Gaumer, S., Haacke, A., Tzvetkov, N., Albrecht, M., Evert, B. O., et al. (2006). An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J. 25, 1547-1558. doi:10.1038/sj.emboj.7601043
16. Brais, B. (2003). Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease. Cytogenet. Genome Res. 100, 252-260. doi:10.1159/000072861
17. Brouwer, J. R., Willemsen, R., and Oostra, B. A. (2009). Microsatellite repeat instability and neurological disease. Bioessays 31, 71-83. doi:10.1002/bies.080122
18. Bulone, D., Masino, L., Thomas, D. J., San Biagio, P. L., and Pastore, A. (2006). The interplay between PolyQ and protein context delays aggregation by forming a reservoir of protofibrils. PLoS ONE 1, e111. doi, 10.1371/journal.pone.0000111
19. Burnett, B., Li, F., and Pittman, R. N. (2003). The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum. Mol. Genet. 12, 3195-3205. doi, 10.1093/hmg/ddg344
20. Burnett, B. G., and Pittman, R. N. (2005). The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation. Proc. Natl. Acad. Sci. U.S.A. 102, 4330-4335. doi, 10.1073/pnas.0407252102
21. Butland, S. L., Devon, R. S., Huang, Y., Mead, C. L., Meynert, A. M., Neal, S. J., et al. (2007). CAG-encoded polyglutamine length polymorphism in the human genome. BMC Genomics 8, 126. doi, 10.1186/1471-2164-8-126
22. Ceol, A., Chatr Aryamontri, A., Licata, L., Peluso, D., Briganti, L., Perfetto, L., et al. (2010). MINT, the molecular interaction database, 2009 update. Nucleic Acids Res. 38, D532-539. doi, 10.1093/nar/gkp983
23. Chai, Y., Berke, S. S., Cohen, R. E., and Paulson, H. L. (2004). Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. J. Biol. Chem. 279, 3605-3611. doi, 10.1074/jbc.M310939200
24. Chen, S., Berthelier, V., Hamilton, J. B., O'nuallain, B., and Wetzel, R. (2002a). Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry 41, 7391-7399. doi, 10.1021/bi011772q
25. Chen, S., Ferrone, F. A., and Wetzel, R. (2002b). Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. U.S.A. 99, 11884-11889. doi, 10.1073/pnas.182276099
26. Chen, Y. W., Stott, K., and Perutz, M. F. (1999). Crystal structure of a dimeric chymotrypsin inhibitor 2 mutant containing an inserted glutamine repeat. Proc. Natl. Acad. Sci. U.S.A. 96, 1257-1261. doi, 10.1073/pnas.96.4.1257
27. Chow, M. K., Ellisdon, A. M., Cabrita, L. D., and Bottomley, S. P. (2004a). Polyglutamine expansion in ataxin-3 does not affect protein stability, implications for misfolding and disease. J. Biol. Chem. 279, 47643-47651. doi, 10.1074/jbc.M405799200
28. Chow, M. K., Mackay, J. P., Whisstock, J. C., Scanlon, M. J., and Bottomley, S. P. (2004b). Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3. Biochem. Biophys. Res. Commun. 322, 387-394. doi, 10.1016/j.bbrc.2004.07.131
29. Chow, M. K., Paulson, H. L., and Bottomley, S. P. (2004c). Destabilization of a non-pathological variant of ataxin-3 results in fibrillogenesis via a partially folded intermediate, a model for misfolding in polyglutamine disease. J. Mol. Biol. 335, 333-341. doi, 10.1016/j.jmb.2003.08.064
30. Chu-Wang, I. W., and Oppenheim, R. W. (1978). Cell death of motoneurons in the chick embryo spinal cord. I. A light and electron microscopic study of naturally occurring and induced cell loss during development. J. Comp. Neurol. 177, 33-57. doi, 10.1002/cne.901770105
31. Costa, M. C., Gomes-Da-Silva, J., Miranda, C. J., Sequeiros, J., Santos, M. M., and Maciel, P. (2004). Genomic structure, promoter activity, and developmental expression of the mouse homologue of the Machado-Joseph disease (MJD) gene. Genomics 84, 361-373. doi, 10.1016/j.ygeno.2004.02.012
32. Costa Mdo, C., and Paulson, H. L. (2012). Toward understanding Machado-Joseph disease. Prog. Neurobiol. 97, 239-257. doi, 10.1016/j.pneurobio.2011.11.006
33. Coutinho, P., and Andrade, C. (1978). Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions. Neurology 28, 703-709. doi, 10.1212/WNL.28.7.703
34. Coutinho, P., Guimaraes, A., and Scaravilli, F. (1982). The pathology of Machado-Joseph disease. Report of a possible homozygous case. Acta Neuropathol. 58, 48-54. doi, 10.1007/BF00692697
35. Crick, S. L., Jayaraman, M., Frieden, C., Wetzel, R., and Pappu, R. V. (2006). Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions. Proc. Natl. Acad. Sci. U.S.A. 103, 16764-16769. doi, 10.1073/pnas.0608175103
36. Cushman, M., Johnson, B. S., King, O. D., Gitler, A. D., and Shorter, J. (2010). Prion-like disorders, blurring the divide between transmissibility and infectivity. J. Cell. Sci. 123, 1191-1201. doi, 10.1242/jcs.051672
37. Davies, S. W., Turmaine, M., Cozens, B. A., Difiglia, M., Sharp, A. H., Ross, C. A., et al. (1997). Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548. doi, 10.1016/S0092-8674(00)80513-9
38. de Chiara, C., Menon, R. P., Dal Piaz, F., Calder, L., and Pastore, A. (2005). Polyglutamine is not all, the functional role of the AXH domain in the ataxin-1 protein. J. Mol. Biol. 354, 883-893. doi, 10.1016/j.jmb.2005.09.083
39. de Mezer, M., Wojciechowska, M., Napierala, M., Sobczak, K., and Krzyzosiak, W. J. (2011). Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference. Nucleic Acids Res. 39, 3852-3863. doi, 10.1093/nar/gkq1323
40. Doss-Pepe, E. W., Stenroos, E. S., Johnson, W. G., and Madura, K. (2003). Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. Mol. Cell. Biol. 23, 6469-6483. doi, 10.1128/MCB.23.18.6469-6483.2003
41. Dosztanyi, Z., Chen, J., Dunker, A. K., Simon, I., and Tompa, P. (2006). Disorder and sequence repeats in hub proteins and their implications for network evolution. J. Proteome Res. 5, 2985-2995. doi, 10.1021/pr060171o
42. Dougan, L., Li, J., Badilla, C. L., Berne, B. J., and Fernandez, J. M. (2009). Single homopolypeptide chains collapse into mechanically rigid conformations. Proc. Natl. Acad. Sci. U.S.A. 106, 12605-12610. doi, 10.1073/pnas.0900678106
43. Durcan, T. M., and Fon, E. A. (2013). Ataxin-3 and its e3 partners, implications for Machado-Joseph disease. Front Neurol 4, 46. doi, 10.3389/fneur.2013.00046
44. Durcan, T. M., Kontogiannea, M., Bedard, N., Wing, S. S., and Fon, E. A. (2012). Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme. J. Biol. Chem. 287, 531-541. doi, 10.1074/jbc.M111.288449
45. Durcan, T. M., Kontogiannea, M., Thorarinsdottir, T., Fallon, L., Williams, A. J., Djarmati, A., et al. (2011). The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. Hum. Mol. Genet. 20, 141-154. doi, 10.1093/hmg/ddq452
46. Ellisdon, A. M., Pearce, M. C., and Bottomley, S. P. (2007). Mechanisms of ataxin-3 misfolding and fibril formation, kinetic analysis of a disease-associated polyglutamine protein. J. Mol. Biol. 368, 595-605. doi, 10.1016/j.jmb.2007.02.058
47. Ellisdon, A. M., Thomas, B., and Bottomley, S. P. (2006). The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step. J. Biol. Chem. 281, 16888-16896. doi, 10.1074/jbc.M601470200
48. Evert, B. O., Araujo, J., Vieira-Saecker, A. M., De Vos, R. A., Harendza, S., Klockgether, T., et al. (2006). Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation. J. Neurosci. 26, 11474-11486. doi, 10.1523/JNEUROSCI.2053-06.2006
49. Faux, N. G., Bottomley, S. P., Lesk, A. M., Irving, J. A., Morrison, J. R., De La Banda, M. G., et al. (2005). Functional insights from the distribution and role of homopeptide repeat-containing proteins. Genome Res. 15, 537-551. doi, 10.1101/gr.3096505
50. Fei, E., Jia, N., Zhang, T., Ma, X., Wang, H., Liu, C., et al. (2007). Phosphorylation of ataxin-3 by glycogen synthase kinase 3beta at serine 256 regulates the aggregation of ataxin-3. Biochem. Biophys. Res. Commun. 357, 487-492. doi, 10.1016/j.bbrc.2007.03.160
51. Ferro, A., Carvalho, A. L., Teixeira-Castro, A., Almeida, C., Tome, R. J., Cortes, L., et al. (2007). NEDD8, a new ataxin-3 interactor. Biochim. Biophys. Acta 1773, 1619-1627. doi, 10.1016/j.bbamcr.2007.07.012
52. Fiumara, F., Fioriti, L., Kandel, E. R., and Hendrickson, W. A. (2010). Essential role of coiled coils for aggregation and activity of Q/N-rich prions and PolyQ proteins. Cell 143, 1121-1135. doi, 10.1016/j.cell.2010.11.042
53. Fondon, J. W. III, and Garner, H. R. (2004). Molecular origins of rapid and continuous morphological evolution. Proc. Natl. Acad. Sci. U.S.A. 101, 18058-18063. doi, 10.1073/pnas.0408118101
54. Friedman, M. J., Shah, A. G., Fang, Z. H., Ward, E. G., Warren, S. T., Li, S., et al. (2007). Polyglutamine domain modulates the TBP-TFIIB interaction, implications for its normal function and neurodegeneration. Nat. Neurosci. 10, 1519-1528. doi, 10.1038/nn2011
55. Gales, L., Cortes, L., Almeida, C., Melo, C. V., Costa, M. C., Maciel, P., et al. (2005). Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease, trapping early oligomers of non-expanded ataxin-3. J. Mol. Biol. 353, 642-654. doi, 10.1016/j.jmb.2005.08.061
56. Gerber, H. P., Seipel, K., Georgiev, O., Hofferer, M., Hug, M., Rusconi, S., et al. (1994). Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263, 808-811. doi, 10.1126/science.8303297
57. Goehler, H., Lalowski, M., Stelzl, U., Waelter, S., Stroedicke, M., Worm, U., et al. (2004). A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Mol. Cell 15, 853-865. doi, 10.1016/j.molcel.2004.09.016
58. Gojobori, J., and Ueda, S. (2011). Elevated evolutionary rate in genes with homopolymeric amino acid repeats constituting nondisordered structure. Mol. Biol. Evol. 28, 543-550. doi, 10.1093/molbev/msq225
59. Gonitel, R., Moffitt, H., Sathasivam, K., Woodman, B., Detloff, P. J., Faull, R. L., et al. (2008). DNA instability in postmitotic neurons. Proc. Natl. Acad. Sci. U.S.A. 105, 3467-3472. doi, 10.1073/pnas.0800048105
60. Goto, J., Watanabe, M., Ichikawa, Y., Yee, S. B., Ihara, N., Endo, K., et al. (1997). Machado-Joseph disease gene products carrying different carboxyl termini. Neurosci. Res. 28, 373-377. doi, 10.1016/S0168-0102(97)00056-4
61. Guo, L., Han, A., Bates, D. L., Cao, J., and Chen, L. (2007). Crystal structure of a conserved N-terminal domain of histone deacetylase 4 reveals functional insights into glutamine-rich domains. Proc. Natl. Acad. Sci. U.S.A. 104, 4297-4302. doi, 10.1073/pnas.0608041104
62. Haerty, W., and Golding, G. B. (2010). Low-complexity sequences and single amino acid repeats, not just "junk" peptide sequences. Genome 53, 753-762. doi, 10.1139/g10-063
63. Hammock, E. A., and Young, L. J. (2005). Microsatellite instability generates diversity in brain and sociobehavioral traits. Science 308, 1630-1634. doi, 10.1126/science.1111427
64. Hancock, J. M., and Simon, M. (2005). Simple sequence repeats in proteins and their significance for network evolution. Gene 345, 113-118. doi, 10.1016/j.gene.2004.11.023
65. Harris, G. M., Dodelzon, K., Gong, L., Gonzalez-Alegre, P., and Paulson, H. L. (2010). Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties. PLoS ONE 5, e13695. doi, 10.1371/journal.pone.0013695
66. Heir, R., Ablasou, C., Dumontier, E., Elliott, M., Fagotto-Kaufmann, C., and Bedford, F. K. (2006). The UBL domain of PLIC-1 regulates aggresome formation. EMBO Rep. 7, 1252-1258. doi, 10.1038/sj.embor.7400823
67. Hirabayashi, M., Inoue, K., Tanaka, K., Nakadate, K., Ohsawa, Y., Kamei, Y., et al. (2001). VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ. 8, 977-984. doi, 10.1038/sj.cdd.4400907
68. Huang, C. C., Faber, P. W., Persichetti, F., Mittal, V., Vonsattel, J. P., Macdonald, M. E., et al. (1998). Amyloid formation by mutant huntingtin, threshold, progressivity and recruitment of normal polyglutamine proteins. Somat. Cell Mol. Genet. 24, 217-233. doi, 10.1023/B, SCAM.0000007124.19463.e5
69. Huntley, M. A., and Golding, G. B. (2002). Simple sequences are rare in the Protein Data Bank. Proteins 48, 134-140. doi, 10.1002/prot.10150
70. Jana, N. R., Dikshit, P., Goswami, A., Kotliarova, S., Murata, S., Tanaka, K., et al. (2005). Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes. J. Biol. Chem. 280, 11635-11640. doi, 10.1074/jbc.M412042200
71. Jayaraman, M., Thakur, A. K., Kar, K., Kodali, R., and Wetzel, R. (2011). Assays for studying nucleated aggregation of polyglutamine proteins. Methods 53, 246-254. doi, 10.1016/j.ymeth.2011.01.001
72. Kaltenbach, L. S., Romero, E., Becklin, R. R., Chettier, R., Bell, R., Phansalkar, A., et al. (2007). Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet. 3, e82. doi, 10.1371/journal.pgen.0030082
73. Kar, K., Jayaraman, M., Sahoo, B., Kodali, R., and Wetzel, R. (2011). Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent. Nat. Struct. Mol. Biol. 18, 328-336. doi, 10.1038/nsmb.1992
74. Kashi, Y., King, D., and Soller, M. (1997). Simple sequence repeats as a source of quantitative genetic variation. Trends Genet. 13, 74-78. doi, 10.1016/S0168-9525(97)01008-1
75. Kashi, Y., and King, D. G. (2006). Simple sequence repeats as advantageous mutators in evolution. Trends Genet. 22, 253-259. doi, 10.1016/j.tig.2006.03.005
76. Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., et al. (1994). CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 8, 221-228. doi, 10.1038/ng1194-221
77. Kayed, R., Head, E., Thompson, J. L., Mcintire, T. M., Milton, S. C., Cotman, C. W., et al. (2003). Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489. doi, 10.1126/science.1079469
78. Kiliszek, A., Kierzek, R., Krzyzosiak, W. J., and Rypniewski, W. (2010). Atomic resolution structure of CAG RNA repeats, structural insights and implications for the trinucleotide repeat expansion diseases. Nucleic Acids Res. 38, 8370-8376. doi, 10.1093/nar/gkq700
79. Kiliszek, A., Kierzek, R., Krzyzosiak, W. J., and Rypniewski, W. (2011). Crystal structures of CGG RNA repeats with implications for fragile X-associated tremor ataxia syndrome. Nucleic Acids Res. 39, 7308-7315. doi, 10.1093/nar/gkr368
80. Kim, M. W., Chelliah, Y., Kim, S. W., Otwinowski, Z., and Bezprozvanny, I. (2009). Secondary structure of Huntingtin amino-terminal region. Structure 17, 1205-1212. doi, 10.1016/j.str.2009.08.002
81. King, D. G. (1994). Triple repeat DNA as a highly mutable regulatory mechanism. Science 263, 595-596. doi, 10.1126/science.263.5147.595-b
82. Klein, F. A., Pastore, A., Masino, L., Zeder-Lutz, G., Nierengarten, H., Oulad-Abdelghani, M., et al. (2007). Pathogenic and non-pathogenic polyglutamine tracts have similar structural properties, towards a length-dependent toxicity gradient. J. Mol. Biol. 371, 235-244. doi, 10.1016/j.jmb.2007.05.028
83. Korschen, H. G., Beyermann, M., Muller, F., Heck, M., Vantler, M., Koch, K. W., et al. (1999). Interaction of glutamic-acid-rich proteins with the cGMP signalling pathway in rod photoreceptors. Nature 400, 761-766. doi, 10.1038/23468
84. Kratter, I. H., and Finkbeiner, S. (2010). PolyQ disease, too many Qs, too much function?. Neuron 67, 897-899. doi, 10.1016/j.neuron.2010.09.012
85. Krull, L. H., Wall, J. S., Zobel, H., and Dimler, R. J. (1965). Synthetic polypeptides containing side-chain amide groups, water-insoluble polymers. Biochemistry 4, 626-633. doi, 10.1021/bi00880a003
86. Krzyzosiak, W. J., Sobczak, K., Wojciechowska, M., Fiszer, A., Mykowska, A., and Kozlowski, P. (2012). Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target. Nucleic Acids Res. 40, 11-26. doi, 10.1093/nar/gkr729
87. Kumar, A., Park, H., Fang, P., Parkesh, R., Guo, M., Nettles, K. W., et al. (2011). Myotonic dystrophy type 1 RNA crystal structures reveal heterogeneous 1×1 nucleotide UU internal loop conformations. Biochemistry 50, 9928-9935. doi, 10.1021/bi2013068
88. La Spada, A. R. (1997). Trinucleotide repeat instability, genetic features and molecular mechanisms. Brain Pathol. 7, 943-963. doi, 10.1111/j.1750-3639.1997.tb00895.x
89. La Spada, A. R., Paulson, H. L., and Fischbeck, K. H. (1994). Trinucleotide repeat expansion in neurological disease. Ann. Neurol. 36, 814-822. doi, 10.1002/ana.410360604
90. La Spada, A. R., Wilson, E. M., Lubahn, D. B., Harding, A. E., and Fischbeck, K. H. (1991). Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77-79. doi, 10.1038/352077a0
91. Laganowsky, A., Liu, C., Sawaya, M. R., Whitelegge, J. P., Park, J., Zhao, M., et al. (2012). Atomic view of a toxic amyloid small oligomer. Science 335, 1228-1231. doi, 10.1126/science.1213151
92. Li, F., Macfarlan, T., Pittman, R. N., and Chakravarti, D. (2002). Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J. Biol. Chem. 277, 45004-45012. doi, 10.1074/jbc.M205259200
93. Li, L. B., and Bonini, N. M. (2010). Roles of trinucleotide-repeat RNA in neurological disease and degeneration. Trends Neurosci. 33, 292-298. doi, 10.1016/j.tins.2010.03.004
94. Li, P., Huey-Tubman, K. E., Gao, T., Li, X., West, A. P. Jr., Bennett, M. J., et al. (2007a). The structure of a polyQ-anti-polyQ complex reveals binding according to a linear lattice model. Nat. Struct. Mol. Biol. 14, 381-387. doi, 10.1038/nsmb1234
95. Li, X. J., Friedman, M., and Li, S. (2007b). Interacting proteins as genetic modifiers of Huntington disease. Trends Genet. 23, 531-533. doi, 10.1016/j.tig.2007.07.007
96. Liebman, S. W., and Meredith, S. C. (2010). Protein folding, sticky N17 speeds huntingtin pile-up. Nat. Chem. Biol. 6, 7-8. doi, 10.1038/nchembio.279
97. Lim, J., Crespo-Barreto, J., Jafar-Nejad, P., Bowman, A. B., Richman, R., Hill, D. E., et al. (2008). Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature 452, 713-718. doi, 10.1038/nature06731
98. Lim, J., Hao, T., Shaw, C., Patel, A. J., Szabo, G., Rual, J. F., et al. (2006). A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125, 801-814. doi, 10.1016/j.cell.2006.03.032
99. Liu, Y., Gotte, G., Libonati, M., and Eisenberg, D. (2001). A domain-swapped RNase A dimer with implications for amyloid formation. Nat. Struct. Biol. 8, 211-214. doi, 10.1038/84941
100. Lopez Castel, A., Cleary, J. D., and Pearson, C. E. (2010). Repeat instability as the basis for human diseases and as a potential target for therapy. Nat. Rev. Mol. Cell Biol. 11, 165-170. doi, 10.1038/nrm2854
101. Macedo-Ribeiro, S., Cortes, L., Maciel, P., and Carvalho, A. L. (2009). Nucleocytoplasmic shuttling activity of ataxin-3. PLoS ONE 4, e5834. doi, 10.1371/journal.pone.0005834
102. Mao, Y., Senic-Matuglia, F., Di Fiore, P. P., Polo, S., Hodsdon, M. E., and De Camilli, P. (2005). Deubiquitinating function of ataxin-3, insights from the solution structure of the Josephin domain. Proc. Natl. Acad. Sci. U.S.A. 102, 12700-12705. doi, 10.1073/pnas.0506344102
103. Marchal, S., Shehi, E., Harricane, M. C., Fusi, P., Heitz, F., Tortora, P., et al. (2003). Structural instability and fibrillar aggregation of non-expanded human ataxin-3 revealed under high pressure and temperature. J. Biol. Chem. 278, 31554-31563. doi, 10.1074/jbc.M304205200
104. Margolis, R. L., and Ross, C. A. (2001). Expansion explosion, new clues to the pathogenesis of repeat expansion neurodegenerative diseases. Trends. Mol. Med. 7, 479-482. doi, 10.1016/S1471-4914(01)02179-7
105. Masino, L., Kelly, G., Leonard, K., Trottier, Y., and Pastore, A. (2002). Solution structure of polyglutamine tracts in GST-polyglutamine fusion proteins. FEBS Lett. 513, 267-272. doi, 10.1016/S0014-5793(02)02335-9
106. Masino, L., Musi, V., Menon, R. P., Fusi, P., Kelly, G., Frenkiel, T. A., et al. (2003). Domain architecture of the polyglutamine protein ataxin-3, a globular domain followed by a flexible tail. FEBS Lett. 549, 21-25. doi, 10.1016/S0014-5793(03)00748-8
107. Masino, L., Nicastro, G., Calder, L., Vendruscolo, M., and Pastore, A. (2011). Functional interactions as a survival strategy against abnormal aggregation. FASEB J. 25, 45-54. doi, 10.1096/fj.10-161208
108. Masino, L., Nicastro, G., Menon, R. P., Dal Piaz, F., Calder, L., and Pastore, A. (2004). Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3. J. Mol. Biol. 344, 1021-1035. doi, 10.1016/j.jmb.2004.09.065
109. Matos, C. A., De Macedo-Ribeiro, S., and Carvalho, A. L. (2011). Polyglutamine diseases, the special case of ataxin-3 and Machado-Joseph disease. Prog. Neurobiol. 95, 26-48. doi, 10.1016/j.pneurobio.2011.06.007
110. Matsumoto, M., Yada, M., Hatakeyama, S., Ishimoto, H., Tanimura, T., Tsuji, S., et al. (2004). Molecular clearance of ataxin-3 is regulated by a mammalian E4. EMBO J. 23, 659-669. doi, 10.1038/sj.emboj.7600081
111. Mazzucchelli, S., De Palma, A., Riva, M., D'urzo, A., Pozzi, C., Pastori, V., et al. (2009). Proteomic and biochemical analyses unveil tight interaction of ataxin-3 with tubulin. Int. J. Biochem. Cell Biol. 41, 2485-2492. doi, 10.1016/j.biocel.2009.08.003
112. McGurk, L., and Bonini, N. M. (2012). Protein interacting with C kinase (PICK1) is a suppressor of spinocerebellar ataxia 3-associated neurodegeneration in Drosophila. Hum. Mol. Genet. 21, 76-84. doi, 10.1093/hmg/ddr439
113. Merienne, K., and Trottier, Y. (2009). SCA8 CAG/CTG expansions, a tale of two TOXICities, a unique or common case?. PLoS Genet. 5, e1000593. doi, 10.1371/journal.pgen.1000593
114. Messaed, C., Dion, P. A., Abu-Baker, A., Rochefort, D., Laganiere, J., Brais, B., et al. (2007). Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy. Neurobiol. Dis. 26, 546-557. doi, 10.1016/j.nbd.2007.02.004
115. Messaed, C., and Rouleau, G. A. (2009). Molecular mechanisms underlying polyalanine diseases. Neurobiol. Dis. 34, 397-405. doi, 10.1016/j.nbd.2009.02.013
116. Miller, J., Arrasate, M., Brooks, E., Libeu, C. P., Legleiter, J., Hatters, D., et al. (2011). Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat. Chem. Biol. 7, 925-934. doi, 10.1038/nchembio.694
117. Miller, J., Arrasate, M., Shaby, B. A., Mitra, S., Masliah, E., and Finkbeiner, S. (2010). Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis. J. Neurosci. 30, 10541-10550. doi, 10.1523/JNEUROSCI.0146-10.2010
118. Miller, J. W., Urbinati, C. R., Teng-Umnuay, P., Stenberg, M. G., Byrne, B. J., Thornton, C. A., et al. (2000). Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19, 4439-4448. doi, 10.1093/emboj/19.17.4439
119. Miller, V. M., Nelson, R. F., Gouvion, C. M., Williams, A., Rodriguez-Lebron, E., Harper, S. Q., et al. (2005). CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo. J. Neurosci. 25, 9152-9161. doi, 10.1523/JNEUROSCI.3001-05.2005
120. Mooers, B. H., Logue, J. S., and Berglund, J. A. (2005). The structural basis of myotonic dystrophy from the crystal structure of CUG repeats. Proc. Natl. Acad. Sci. U.S.A. 102, 16626-16631. doi, 10.1073/pnas.0505873102
121. Mosca, R., Ceol, A., and Aloy, P. (2012). Interactome3D, adding structural details to protein networks. Nat. Methods 10, 47-53. doi, 10.1038/nmeth.2289
122. Mueller, T., Breuer, P., Schmitt, I., Walter, J., Evert, B. O., and Wullner, U. (2009). CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3. Hum. Mol. Genet. 18, 3334-3343. doi, 10.1093/hmg/ddp274
123. Nagai, Y., Inui, T., Popiel, H. A., Fujikake, N., Hasegawa, K., Urade, Y., et al. (2007). A toxic monomeric conformer of the polyglutamine protein. Nat. Struct. Mol. Biol. 14, 332-340. doi, 10.1038/nsmb1215
124. Napierala, M., and Krzyzosiak, W. J. (1997). CUG repeats present in myotonin kinase RNA form metastable "slippery" hairpins. J. Biol. Chem. 272, 31079-31085. doi, 10.1074/jbc.272.49.31079
125. Nicastro, G., Masino, L., Esposito, V., Menon, R. P., De Simone, A., Fraternali, F., et al. (2009). Josephin domain of ataxin-3 contains two distinct ubiquitin-binding sites. Biopolymers 91, 1203-1214. doi, 10.1002/bip.21210
126. Nicastro, G., Menon, R. P., Masino, L., Knowles, P. P., Mcdonald, N. Q., and Pastore, A. (2005). The solution structure of the Josephin domain of ataxin-3, structural determinants for molecular recognition. Proc. Natl. Acad. Sci. U.S.A. 102, 10493-10498. doi, 10.1073/pnas.0501732102
127. Nicastro, G., Todi, S. V., Karaca, E., Bonvin, A. M., Paulson, H. L., and Pastore, A. (2010). Understanding the role of the Josephin domain in the PolyUb binding and cleavage properties of ataxin-3. PLoS ONE 5, e12430. doi, 10.1371/journal.pone.0012430
128. Nithianantharajah, J., and Hannan, A. J. (2007). Dynamic mutations as digital genetic modulators of brain development, function and dysfunction. Bioessays 29, 525-535. doi, 10.1002/bies.20589
129. Nucifora, F. C. Jr., Sasaki, M., Peters, M. F., Huang, H., Cooper, J. K., Yamada, M., et al. (2001). Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291, 2423-2428. doi, 10.1126/science.1056784
130. Oma, Y., Kino, Y., Sasagawa, N., and Ishiura, S. (2005). Comparative analysis of the cytotoxicity of homopolymeric amino acids. Biochim. Biophys. Acta 1748, 174-179. doi, 10.1016/j.bbapap.2004.12.017
131. Oma, Y., Kino, Y., Toriumi, K., Sasagawa, N., and Ishiura, S. (2007). Interactions between homopolymeric amino acids (HPAAs). Protein Sci. 16, 2195-2204. doi, 10.1110/ps.072955307
132. Ordway, J. M., Tallaksengreene, S., Gutekunst, C. A., Bernstein, E. M., Cearley, J. A., Wiener, H. W., et al. (1997). Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 91, 753-763. doi, 10.1016/S0092-8674(00)80464-X
133. Orr, H. T. (2012a). Cell biology of spinocerebellar ataxia. J. Cell Biol. 197, 167-177. doi, 10.1083/jcb.201105092
134. Orr, H. T. (2012b). Polyglutamine neurodegeneration, expanded glutamines enhance native functions. Curr. Opin. Genet. Dev. 22, 251-255. doi, 10.1016/j.gde.2012.01.001
135. Orr, H. T., and Zoghbi, H. Y. (2007). Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30, 575-621. doi, 10.1146/annurev.neuro.29.051605.113042
136. Parkesh, R., Fountain, M., and Disney, M. D. (2011). NMR spectroscopy and molecular dynamics simulation of r(CCGCUGCGG) reveal a dynamic UU internal loop found in myotonic dystrophy type 1. Biochemistry 50, 599-601. doi, 10.1021/bi101896j
137. Parry, D. A., Fraser, R. D., and Squire, J. M. (2008). Fifty years of coiled-coils and alpha-helical bundles, a close relationship between sequence and structure. J. Struct. Biol. 163, 258-269. doi, 10.1016/j.jsb.2008.01.016
138. Pastore, A., and Temussi, P. A. (2012). The two faces of Janus, functional interactions and protein aggregation. Curr. Opin. Struct. Biol. 22, 30-37. doi, 10.1016/j.sbi.2011.11.007
139. Paulson, H. L., Perez, M. K., Trottier, Y., Trojanowski, J. Q., Subramony, S. H., Das, S. S., et al. (1997). Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333-344. doi, 10.1016/S0896-6273(00)80943-5
140. Pearson, C. E. (2011). Repeat associated non-ATG translation initiation, one DNA, two transcripts, seven reading frames, potentially nine toxic entities! PLoS Genet. 7, e1002018. doi, 10.1371/journal.pgen.1002018
141. Pearson, C. E., Nichol Edamura, K., and Cleary, J. D. (2005). Repeat instability, mechanisms of dynamic mutations. Nat. Rev. Genet. 6, 729-742. doi, 10.1038/nrg1689
142. Perez, M. K., Paulson, H. L., Pendse, S. J., Saionz, S. J., Bonini, N. M., and Pittman, R. N. (1998). Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J. Cell Biol. 143, 1457-1470. doi, 10.1083/jcb.143.6.1457
143. Perez, M. K., Paulson, H. L., and Pittman, R. N. (1999). Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix. Hum. Mol. Genet. 8, 2377-2385. doi, 10.1093/hmg/8.13.2377
144. Perutz, M. (1994). Polar zippers, their role in human disease. Protein Sci. 3, 1629-1637. doi, 10.1002/pro.5560031002
145. Peters-Libeu, C., Miller, J., Rutenber, E., Newhouse, Y., Krishnan, P., Cheung, K., et al. (2012). Disease-associated polyglutamine stretches in monomeric huntingtin adopt a compact structure. J. Mol. Biol. 421, 587-600. doi, 10.1016/j.jmb.2012.01.034
146. Petrakis, S., Rasko, T., Russ, J., Friedrich, R. P., Stroedicke, M., Riechers, S. P., et al. (2012). Identification of human proteins that modify misfolding and proteotoxicity of pathogenic ataxin-1. PLoS Genet. 8, e1002897. doi, 10.1371/journal.pgen.1002897
147. Pilar, G., and Landmesser, L. (1976). Ultrastructural differences during embryonic cell death in normal and peripherally deprived ciliary ganglia. J. Cell Biol. 68, 339-356. doi, 10.1083/jcb.68.2.339
148. Ravasi, T., Suzuki, H., Cannistraci, C. V., Katayama, S., Bajic, V. B., Tan, K., et al. (2010). An atlas of combinatorial transcriptional regulation in mouse and man. Cell 140, 744-752. doi, 10.1016/j.cell.2010.01.044
149. Reina, C. P., Zhong, X., and Pittman, R. N. (2010). Proteotoxic stress increases nuclear localization of ataxin-3. Hum. Mol. Genet. 19, 235-249. doi, 10.1093/hmg/ddp482
150. Ren, P. H., Lauckner, J. E., Kachirskaia, I., Heuser, J. E., Melki, R., and Kopito, R. R. (2009). Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat. Cell Biol. 11, 219-225. doi, 10.1038/ncb1830
151. Robertson, A. L., Bate, M. A., Androulakis, S. G., Bottomley, S. P., and Buckle, A. M. (2011). PolyQ, a database describing the sequence and domain context of polyglutamine repeats in proteins. Nucleic Acids Res. 39, D272-D276. doi, 10.1093/nar/gkq1100
152. Robertson, A. L., Headey, S. J., Saunders, H. M., Ecroyd, H., Scanlon, M. J., Carver, J. A., et al. (2010). Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation. Proc. Natl. Acad. Sci. U.S.A. 107, 10424-10429. doi, 10.1073/pnas.0914773107
153. Robertson, A. L., Horne, J., Ellisdon, A. M., Thomas, B., Scanlon, M. J., and Bottomley, S. P. (2008). The structural impact of a polyglutamine tract is location-dependent. Biophys. J. 95, 5922-5930. doi, 10.1529/biophysj.108.138487
154. Rodrigues, A. J., Coppola, G., Santos, C., Costa Mdo, C., Ailion, M., Sequeiros, J., et al. (2007). Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3. FASEB J. 21, 1126-1136. doi, 10.1096/fj.06-7002com
155. Rohrberg, J., Sachs, R., Lodderstedt, G., Sackewitz, M., Balbach, J., and Schwarz, E. (2008). Monitoring fibril formation of the N-terminal domain of PABPN1 carrying an alanine repeat by tryptophan fluorescence and real-time NMR. FEBS Lett. 582, 1587-1592. doi, 10.1016/j.febslet.2008.04.002
156. Rosenberg, R. N. (1992). Machado-Joseph disease, an autosomal dominant motor system degeneration. Mov. Disord. 7, 193-203. doi, 10.1002/mds.870070302
157. Rub, U., De Vos, R. A., Brunt, E. R., Sebesteny, T., Schols, L., Auburger, G., et al. (2006). Spinocerebellar ataxia type 3 (SCA3), thalamic neurodegeneration occurs independently from thalamic ataxin-3 immunopositive neuronal intranuclear inclusions. Brain Pathol. 16, 218-227. doi, 10.1111/j.1750-3639.2006.00022.x
158. Sambashivan, S., Liu, Y., Sawaya, M. R., Gingery, M., and Eisenberg, D. (2005). Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure. Nature 437, 266-269. doi, 10.1038/nature03916
159. Santambrogio, C., Frana, A. M., Natalello, A., Papaleo, E., Regonesi, M. E., Doglia, S. M., et al. (2012). The role of the central flexible region on the aggregation and conformational properties of human ataxin-3. FEBS J. 279, 451-463. doi, 10.1111/j.1742-4658.2011.08438.x
160. Sathasivam, K., Lane, A., Legleiter, J., Warley, A., Woodman, B., Finkbeiner, S., et al. (2010). Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease. Hum. Mol. Genet. 19, 65-78. doi, 10.1093/hmg/ddp467
161. Saunders, H. M., and Bottomley, S. P. (2009). Multi-domain misfolding, understanding the aggregation pathway of polyglutamine proteins. Protein Eng. Des. Sel. 22, 447-451. doi, 10.1093/protein/gzp033
162. Saunders, H. M., Gilis, D., Rooman, M., Dehouck, Y., Robertson, A. L., and Bottomley, S. P. (2011). Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein. Protein Sci. 20, 1675-1681. doi, 10.1002/pro.698
163. Scaglione, K. M., Zavodszky, E., Todi, S. V., Patury, S., Xu, P., Rodriguez-Lebron, E., et al. (2011). Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP. Mol. Cell 43, 599-612. doi, 10.1016/j.molcel.2011.05.036
164. Scarff, C. A., Sicorello, A., Tomé, R. J. L., Ashcroft, A. E., Radford, S. E., and Macedo-Ribeiro, S. (2012). A tale of a tail, structural insights into the conformational properties of the polyglutamine protein ataxin-3. Int. J. Mass Spectrom. doi, 10.1016/j.ijms.2012.08.032
165. Schaefer, M. H., Wanker, E. E., and Andrade-Navarro, M. A. (2012). Evolution and function of CAG/polyglutamine repeats in protein-protein interaction networks. Nucleic Acids Res. 40, 4273-4287. doi, 10.1093/nar/gks011
166. Scheel, H., Tomiuk, S., and Hofmann, K. (2003). Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics. Hum. Mol. Genet. 12, 2845-2852. doi, 10.1093/hmg/ddg297
167. Scheuermann, T., Schulz, B., Blume, A., Wahle, E., Rudolph, R., and Schwarz, E. (2003). Trinucleotide expansions leading to an extended poly-L-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation. Protein Sci. 12, 2685-2692. doi, 10.1110/ps.03214703
168. Schmitt, I., Linden, M., Khazneh, H., Evert, B. O., Breuer, P., Klockgether, T., et al. (2007). Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination. Biochem. Biophys. Res. Commun. 362, 734-739. doi, 10.1016/j.bbrc.2007.08.062
169. Seki, T., Gong, L., Williams, A. J., Sakai, N., Todi, S. V., and Paulson, H. L. (2013). JosD1, a membrane-targeted deubiquitinating enzyme, is activated by ubiquitination and regulates membrane dynamics, cell motility and endocytosis. J. Biol. Chem. doi, 10.1074/jbc.M113.463406
170. Shimohata, T., Nakajima, T., Yamada, M., Uchida, C., Onodera, O., Naruse, S., et al. (2000). Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat. Genet. 26, 29-36. doi, 10.1038/79139
171. Sicot, G., Gourdon, G., and Gomes-Pereira, M. (2011). Myotonic dystrophy, when simple repeats reveal complex pathogenic entities, new findings and future challenges. Hum. Mol. Genet. 20, R116-123. doi, 10.1093/hmg/ddr343
172. Simon, M., and Hancock, J. M. (2009). Tandem and cryptic amino acid repeats accumulate in disordered regions of proteins. Genome Biol. 10, R59. doi, 10.1186/gb-2009-10-6-r59
173. Singh, V. R., and Lapidus, L. J. (2008). The intrinsic stiffness of polyglutamine peptides. J. Phys. Chem. B 112, 13172-13176. doi, 10.1021/jp805636p
174. Song, A. X., Zhou, C. J., Peng, Y., Gao, X. C., Zhou, Z. R., Fu, Q. S., et al. (2010). Structural transformation of the tandem ubiquitin-interacting motifs in ataxin-3 and their cooperative interactions with ubiquitin chains. PLoS ONE 5, e13202. doi, 10.1371/journal.pone.0013202
175. Sowa, M. E., Bennett, E. J., Gygi, S. P., and Harper, J. W. (2009). Defining the human deubiquitinating enzyme interaction landscape. Cell 138, 389-403. doi, 10.1016/j.cell.2009.04.042
176. Stott, K., Blackburn, J. M., Butler, P. J., and Perutz, M. (1995). Incorporation of glutamine repeats makes protein oligomerize, implications for neurodegenerative diseases. Proc. Natl. Acad. Sci. U.S.A. 92, 6509-6513. doi, 10.1073/pnas.92.14.6509
177. Sugaya, N., and Furuya, T. (2011). Dr. PIAS, an integrative system for assessing the druggability of protein-protein interactions. BMC Bioinformatics 12, 50. doi, 10.1186/1471-2105-12-50
178. Takahashi, T., Kikuchi, S., Katada, S., Nagai, Y., Nishizawa, M., and Onodera, O. (2008). Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. Hum. Mol. Genet. 17, 345-356. doi, 10.1093/hmg/ddm311
179. Tam, S., Spiess, C., Auyeung, W., Joachimiak, L., Chen, B., Poirier, M. A., et al. (2009). The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation. Nat. Struct. Mol. Biol. 16, 1279-1285. doi, 10.1038/nsmb.1700
180. Tanaka, M., Morishima, I., Akagi, T., Hashikawa, T., and Nukina, N. (2001). Intra- and intermolecular beta-pleated sheet formation in glutamine-repeat inserted myoglobin as a model for polyglutamine diseases. J. Biol. Chem. 276, 45470-45475. doi, 10.1074/jbc.M107502200
181. Tao, R. S., Fei, E. K., Ying, Z., Wang, H. F., and Wang, G. H. (2008). Casein kinase 2 interacts with and phosphorylates ataxin-3. Neurosci. Bull. 24, 271-277. doi, 10.1007/s12264-008-0605-5
182. Tavanez, J. P., Bengoechea, R., Berciano, M. T., Lafarga, M., Carmo-Fonseca, M., and Enguita, F. J. (2009). Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1. PLoS ONE 4, e6418. doi, 10.1371/journal.pone.0006418
183. Tavanez, J. P., Calado, P., Braga, J., Lafarga, M., and Carmo-Fonseca, M. (2005). In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1. RNA 11, 752-762. doi, 10.1261/rna.7217105
184. Teplova, M., and Patel, D. J. (2008). Structural insights into RNA recognition by the alternative-splicing regulator muscleblind-like MBNL1. Nat. Struct. Mol. Biol. 15, 1343-1351. doi, 10.1038/nsmb.1519
185. Thakur, A. K., Jayaraman, M., Mishra, R., Thakur, M., Chellgren, V. M., Byeon, I. J., et al. (2009). Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat. Struct. Mol. Biol. 16, 380-389. doi, 10.1038/nsmb.1570
186. Tobelmann, M. D., and Murphy, R. M. (2011). Location trumps length, polyglutamine-mediated changes in folding and aggregation of a host protein. Biophys. J. 100, 2773-2782. doi, 10.1016/j.bpj.2011.04.028
187. Todi, S. V., Winborn, B. J., Scaglione, K. M., Blount, J. R., Travis, S. M., and Paulson, H. L. (2009). Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3. EMBO J. 28, 372-382. doi, 10.1038/emboj.2008.289
188. Tzvetkov, N., and Breuer, P. (2007). Josephin domain-containing proteins from a variety of species are active de-ubiquitination enzymes. Biol. Chem. 388, 973-978. doi, 10.1515/BC.2007.107
189. Ventii, K. H., and Wilkinson, K. D. (2008). Protein partners of deubiquitinating enzymes. Biochem. J. 414, 161-175. doi, 10.1042/BJ20080798
190. Vinayagam, A., Stelzl, U., Foulle, R., Plassmann, S., Zenkner, M., Timm, J., et al. (2011). A directed protein interaction network for investigating intracellular signal transduction. Sci. Signal. 4, rs8. doi, 10.1126/scisignal.2001699
191. Vitalis, A., Lyle, N., and Pappu, R. V. (2009). Thermodynamics of beta-sheet formation in polyglutamine. Biophys. J. 97, 303-311. doi, 10.1016/j.bpj.2009.05.003
192. Walters, R. H., and Murphy, R. M. (2009). Examining polyglutamine peptide length, a connection between collapsed conformations and increased aggregation. J. Mol. Biol. 393, 978-992. doi, 10.1016/j.jmb.2009.08.034
193. Walters, R. H., and Murphy, R. M. (2011). Aggregation kinetics of interrupted polyglutamine peptides. J. Mol. Biol. 412, 505-519. doi, 10.1016/j.jmb.2011.07.003
194. Walum, H., Westberg, L., Henningsson, S., Neiderhiser, J. M., Reiss, D., Igl, W., et al. (2008). Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding behavior in humans. Proc. Natl. Acad. Sci. U.S.A. 105, 14153-14156. doi, 10.1073/pnas.0803081105
195. Wang, G., Sawai, N., Kotliarova, S., Kanazawa, I., and Nukina, N. (2000). Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B. Hum. Mol. Genet. 9, 1795-1803. doi, 10.1093/hmg/9.12.1795
196. Wang, H., Jia, N., Fei, E., Wang, Z., Liu, C., Zhang, T., et al. (2007). p45, an ATPase subunit of the 19S proteasome, targets the polyglutamine disease protein ataxin-3 to the proteasome. J. Neurochem. 101, 1651-1661. doi, 10.1111/j.1471-4159.2007.04460.x
197. Weeks, S. D., Grasty, K. C., Hernandez-Cuebas, L., and Loll, P. J. (2011). Crystal structure of a Josephin-ubiquitin complex, evolutionary restraints on ataxin-3 deubiquitinating activity. J. Biol. Chem. 286, 4555-4565. doi, 10.1074/jbc.M110.177360
198. Weiss, A., Klein, C., Woodman, B., Sathasivam, K., Bibel, M., Regulier, E., et al. (2008). Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease. J. Neurochem. 104, 846-858.
199. Wetzel, R. (2012). Physical chemistry of polyglutamine, intriguing tales of a monotonous sequence. J. Mol. Biol. 421, 466-490. doi, 10.1016/j.jmb.2012.01.030
200. Whan, V., Hobbs, M., Mcwilliam, S., Lynn, D. J., Lutzow, Y. S., Khatkar, M., et al. (2010). Bovine proteins containing poly-glutamine repeats are often polymorphic and enriched for components of transcriptional regulatory complexes. BMC Genomics 11, 654. doi, 10.1186/1471-2164-11-654
201. Williams, A. J., and Paulson, H. L. (2008). Polyglutamine neurodegeneration, protein misfolding revisited. Trends Neurosci. 31, 521-528. doi, 10.1016/j.tins.2008.07.004
202. Williamson, T. E., Vitalis, A., Crick, S. L., and Pappu, R. V. (2010). Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin. J. Mol. Biol. 396, 1295-1309. doi, 10.1016/j.jmb.2009.12.017
203. Winborn, B. J., Travis, S. M., Todi, S. V., Scaglione, K. M., Xu, P., Williams, A. J., et al. (2008). The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains. J. Biol. Chem. 283, 26436-26443. doi, 10.1074/jbc.M803692200
204. Winter, R., Liebold, J., and Schwarz, E. (2013). The unresolved puzzle why alanine extensions cause disease. Biol. Chem. doi, 10.1515/hsz-2013-0112
205. Yuan, Y., Compton, S. A., Sobczak, K., Stenberg, M. G., Thornton, C. A., Griffith, J. D., et al. (2007). Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res. 35, 5474-5486. doi, 10.1093/nar/gkm601
206. Zhai, W., Jeong, H., Cui, L., Krainc, D., and Tjian, R. (2005). In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets. Cell 123, 1241-1253. doi, 10.1016/j.cell.2005.10.030
207. Zhong, X., and Pittman, R. N. (2006). Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates. Hum. Mol. Genet. 15, 2409-2420. doi, 10.1093/hmg/ddl164
208. Zuchner, T., and Brundin, P. (2008). Mutant huntingtin can paradoxically protect neurons from death. Cell Death Differ. 15, 435-442. doi, 10.1038/sj.cdd.440226